Neoadjuvant Trials Could Speed Up Drug Approvals
نویسندگان
چکیده
منابع مشابه
Postmarketing trials and pediatric device approvals.
BACKGROUND Medical devices can be useful in a variety of diseases, but few devices have been specifically approved for use in children. The 2007 Pediatric Medical Device Safety and Improvement Act was passed to stimulate pediatric device development. The current state of trial evidence underpinning the approval of pediatric devices remains poorly described. METHODS We identified all high-risk...
متن کاملHow Could Veins Speed Up The Process Of Discourse Parsing
In this paper we propose a method of reducing the search space of a discourse parsing process, while keeping unaffected its capacity to generate cohesive and coherent tree structures. The parsing method uses Veins Theory (VT), by developing incrementally a forest of parallel discourse trees, evaluating them on cohesion and coherence criteria and keeping only the most promising structures to go ...
متن کاملA critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa
OBJECTIVES To assess the relation between the number of clinical trials conducted and respective new drug approvals in India and South Africa. DESIGN Construction and analysis of a comprehensive database of completed randomised controlled clinical trials based on clinicaltrials.gov from 1 January 2005 to 31 December 2010 and drug approval data from 2006 until 2013 for India and South Africa. ...
متن کاملNEW DRUG APPROVALS Opdivo for Melanoma
NEW DRUG APPROVALS Opdivo for Melanoma Nivolumab injection (Opdivo, BristolMyers Squibb) has received the FDA’s accelerated approval for the treatment of patients with unresectable or metastatic melanoma that has progressed after treatment with specific medications. Nivolumab is a monoclonal antibody that binds to the programmed death-1 (PD-1) receptor and blocks its interaction with ligands PD...
متن کاملNEW DRUG APPROVALS Kybella for Submental Fat
NEW DRUG APPROVALS Kybella for Submental Fat Deoxycholic acid (Kybella, Kythera Biopharmaceuticals Inc.) has received FDA approval to treat moderate-to-severe fat below the chin, called submental fat. The product is not approved or recommended to treat fat outside of the submental area. Kybella is identical to the deoxycholic acid produced in the body, which helps the body absorb fats. A cytoly...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2014
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/dju072